InnoCare Pharma Presents Orelabrutinib Data at ESMO Congress
InnoCare Pharma said data on orelabrutinib were presented at the European Society for Medical Oncology Congress 2026.
Related stories
Jordan Telecommunications Q3 net revenue 95.7 million dinars
M impact | EQUITY | Oct 29, 2026, 02:52 PM UTC
SEG Solar Acquires Land for Planned Cell Factory
SEG Solar acquired land for a planned cell factory.
M impact | EQUITY | Oct 29, 2026, 02:52 PM UTC
Jordan Telecommunications Reports Q3 Profit of 12.4 Million Dinars
M impact | EQUITY | Oct 29, 2026, 02:52 PM UTC
SEG Solar Secures Site for Planned Texas Solar Cell Plant
SEG Solar said it secured land for a planned solar cell factory near Houston, Texas.
M impact | EQUITY | Oct 29, 2026, 02:52 PM UTC
SEG Solar secures land for planned Texas solar cell factory
SEG Solar said it secured land for a planned solar cell factory near Houston, Texas.
L impact | EQUITY | Oct 29, 2026, 02:52 PM UTC
SEG Solar Secures Land for Planned $950 Million Solar Cell Plant
SEG Solar says the planned facility near Houston would add 4 gigawatts of annual manufacturing capacity.
M impact | EQUITY | Oct 29, 2026, 02:51 PM UTC